Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Excluding the Pending Study 2 Data on 27 patients

<< Previous

Bullboard Posts

Next >>

Comment by cashascarson Aug 31, 2021 12:52pm

211 Views

Post# 33788256

RE:RE:RE:RE:Excluding the Pending Study 2 Data on 27 patients

According to the 27 patients graph 52% of them have been accounted for with 48% still pending,
so around 14 patients have reached 450 or have been included in the 450 day end results. 12 of which would have been under treated. So the numbers should get better when the next 13 properly treated hit that interval.
cashascars

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?